Deep Brain Stimulation Eases Parkinson’s Symptoms in Early Disease Stages
source: pixabay.com

Deep Brain Stimulation Eases Parkinson’s Symptoms in Early Disease Stages

  Around 10 million people worldwide are living with Parkinson's disease, a progressive nervous system disorder impacting movement. While there are many current and proposed treatments, the medical community continues…

Continue Reading Deep Brain Stimulation Eases Parkinson’s Symptoms in Early Disease Stages
LUMEVOQ Shows Sustained Efficacy and Safety for Patients with LHON
Source: Pixabay.com

LUMEVOQ Shows Sustained Efficacy and Safety for Patients with LHON

  After three years, patients with Leber hereditary optic neuropathy (LHON) who had been treated with LUMEVOQ experienced sustained safety and efficacy. According to a press release from GenSight Biologics,…

Continue Reading LUMEVOQ Shows Sustained Efficacy and Safety for Patients with LHON

High ROBO2 Protein Levels in Chronic Kidney Disease Point to a New Therapeutic Target

  According to a recent article in EurekaAlert, researchers at the University of Boston recently published their new study investigating ROBO2. The ROBO2 signaling pathway has emerged as a therapeutic…

Continue Reading High ROBO2 Protein Levels in Chronic Kidney Disease Point to a New Therapeutic Target
$6.75 Million in Grants Sets the Stage for the Next Level of Blood Cancer Treatments
source: pixabay.com

$6.75 Million in Grants Sets the Stage for the Next Level of Blood Cancer Treatments

  After forty years of research to counter or cure acute myeloid leukemia and other blood cancers, a few years ago the medical community exploded with eight new cancer drugs.…

Continue Reading $6.75 Million in Grants Sets the Stage for the Next Level of Blood Cancer Treatments
Close Menu